+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fluorescein Angiography Market - Global Forecast 2026-2032- Product Image
Fluorescein Angiography Market - Global Forecast 2026-2032- Product Image
Sale

Fluorescein Angiography Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674975
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fluorescein Angiography Market is projected to reach USD 1.01 Billion in 2026. It is expected to continue growing at a CAGR of 9.12%, reaching USD 1.72 Billion by 2032.

Fluorescein angiography is a core retinal imaging procedure used to visualize retinal and choroidal circulation after intravenous sodium fluorescein administration. It remains clinically important for diabetic retinopathy, neovascular age-related macular degeneration, retinal vein occlusion, uveitis, vascular tumors, and unexplained macular edema.

Demand is reinforced by the global burden of vision-threatening retinal disease. The International Diabetes Federation reported 537 million adults with diabetes in 2021 and projected 643 million by 2030, while peer-reviewed estimates indicate that roughly one in three people with diabetes show signs of diabetic retinopathy. These epidemiologic realities support sustained need for diagnostic retinal angiography alongside OCT, OCT angiography, fundus photography, and multimodal imaging workflows.

Transformative Shifts in the Fluorescein Angiography Landscape

The fluorescein angiography landscape is shifting from episodic image capture toward integrated retinal disease management. Modern retinal clinics increasingly combine FA with OCT, OCTA, widefield imaging, and electronic health records to improve lesion localization, disease staging, treatment planning, and follow-up documentation.

A major transformation is the move toward ultra-widefield angiography, which can reveal peripheral ischemia and vascular leakage that conventional fields may miss. At the same time, anti-VEGF therapy has changed clinical use patterns by making angiography valuable not only for diagnosis but also for monitoring treatment response in neovascular retinal diseases, diabetic macular edema, and vascular occlusions.

Cumulative Impact of Artificial Intelligence on Fluorescein Angiography

Artificial intelligence is amplifying the value of fluorescein angiography by supporting image enhancement, vessel segmentation, leakage detection, ischemic area measurement, and longitudinal comparison. In research settings, deep learning models have shown promise in classifying diabetic retinopathy severity, identifying nonperfusion, and reducing manual grading variability across large retinal image datasets.

However, FA-specific AI is still emerging compared with fundus-photo diabetic retinopathy screening systems that have already achieved regulatory clearance in some markets. The near-term impact will be greatest in decision support, triage, quantitative reporting, and clinical trial endpoint standardization, provided algorithms are validated across camera systems, ethnicities, disease stages, and real-world image quality.

Key Regional Insights for Fluorescein Angiography

Asia-Pacific represents a major clinical base because China and India account for a substantial share of the world’s diabetes population, while Japan, South Korea, and Australia maintain advanced retinal imaging infrastructure. The region’s adoption is supported by expanding hospital ophthalmology departments, urban retina centers, and national diabetic eye disease initiatives, though access remains uneven across rural and lower-resource settings.

North America remains a mature environment supported by retinal subspecialty networks, high adoption of OCT-based workflows, established ophthalmic imaging reimbursement pathways, and strong clinical research activity. Europe benefits from structured ophthalmology training, clinical guideline adoption, universal or near-universal health systems, and strong use of multimodal retinal imaging across Germany, France, Italy, Spain, and the United Kingdom.

Latin America is led by Brazil and Mexico, where expanding private ophthalmology networks coexist with public-sector access constraints and late presentation of diabetic retinopathy in underserved populations. In the Middle East, GCC investment in specialty hospitals and diabetes care supports advanced imaging uptake, while Africa faces the greatest access gap due to limited retina specialists, uneven imaging availability, and delayed diagnosis of preventable vision loss.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is shaped by rising diabetes prevalence, expanding urban eye-care centers, and uneven specialist distribution between metropolitan and rural populations. Countries with stronger tertiary-care infrastructure are adopting multimodal retinal imaging more quickly, while lower-resource settings continue to rely heavily on referral-based diagnosis and targeted screening programs.

The GCC shows stronger purchasing power for premium imaging platforms, supported by government investment in tertiary hospitals, digital health infrastructure, and diabetes-focused prevention programs. The European Union influences quality and access through medical-device regulation, data-protection standards, cross-border research collaboration, and evidence-based ophthalmology guidelines that support standardized retinal imaging practices.

BRICS countries combine large patient pools with heterogeneous reimbursement, procurement, and infrastructure conditions, creating strong long-term clinical need but variable adoption pathways. G7 markets typically lead in clinical trial activity, retinal subspecialty capacity, academic ophthalmology networks, and early adoption of AI-enabled imaging tools. NATO is not a healthcare bloc, but member countries’ procurement standards, cybersecurity priorities, and supply-chain resilience planning can indirectly affect imaging technology deployment in public and defense-linked health systems.

Key Country Insights for Fluorescein Angiography Adoption

The United States leads in retina practice density, clinical trials, and adoption of multimodal imaging, supported by established use of FA for diabetic retinopathy, retinal vein occlusion, inflammatory eye disease, and neovascular age-related macular degeneration. Canada benefits from universal health coverage and strong academic ophthalmology centers but continues to face geographic access challenges across remote and sparsely populated regions.

Mexico and Brazil show rising diagnostic need from diabetic eye disease and expanding private care, though public-sector capacity remains uneven and access to retina specialists is concentrated in major cities. The United Kingdom, Germany, France, Italy, and Spain support angiography through established ophthalmology networks and guideline-based retinal disease management, with Germany and France particularly strong in specialty diagnostics, clinical research, and medical-device adoption.

Russia maintains demand through urban specialty centers despite procurement variability and regional differences in access. China and India offer the largest long-term patient pools because of diabetes prevalence, aging populations, and growing hospital investment, while persistent rural access gaps increase the importance of screening, referral networks, and teleophthalmology. Japan and South Korea combine aging demographics with advanced imaging ecosystems and strong retina subspecialty care. Australia’s retina care is technologically sophisticated but regionally concentrated, making teleophthalmology, diabetic eye screening, and referral pathways important to equitable access.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable platforms that integrate FA, OCT, OCTA, fundus photography, widefield imaging, and electronic health records. Product strategies should emphasize ultra-widefield capability, reliable image quality, efficient dye workflow, safety documentation, and reporting tools that help clinicians document leakage, nonperfusion, neovascularization, macular edema, and treatment response.

Manufacturers and providers should invest in AI validation using diverse datasets, because algorithm performance can vary by camera type, image protocol, disease severity, media opacity, and population characteristics. Commercial teams should also align with retina referral networks, diabetes screening programs, clinical trial sponsors, payer requirements, and public-sector health initiatives to improve adoption in both mature and emerging healthcare systems.

Research Methodology

This executive summary is built from triangulated secondary research, including peer-reviewed ophthalmology literature, public-health datasets, disease-burden estimates, regulatory information, clinical guidelines, technology adoption patterns, and medical imaging workflow evidence. Data sources commonly used in this domain include the International Diabetes Federation, World Health Organization, International Agency for the Prevention of Blindness, national health agencies, medical-device regulatory databases, and ophthalmology society guidance.

The analysis evaluates clinical demand drivers, technology substitution and complementarity, regional healthcare infrastructure, reimbursement maturity, disease screening activity, and AI-readiness. Findings are interpreted through an evidence-based framework that prioritizes verified epidemiology, documented clinical use cases, regulatory context, and observable adoption trends over unsubstantiated projections.

Conclusion

Fluorescein angiography remains a clinically relevant retinal imaging modality despite rapid advances in OCT and OCT angiography. Its ability to reveal vascular leakage, perfusion abnormalities, and dynamic circulation patterns keeps it important for diagnosis, treatment planning, and clinical research in major retinal diseases.

Future value will depend on wider access to retina specialists, integration with multimodal imaging, AI-assisted quantification, and stronger referral pathways for diabetic eye disease. Healthcare systems that combine disease screening, advanced imaging infrastructure, validated digital workflows, and equitable referral models will be best positioned to improve outcomes through fluorescein angiography.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fluorescein Angiography Market, by Product
7.1. Introduction
7.2. Consumables
7.2.1. Dye
7.2.2. Syringes & Needles
7.3. Equipment
7.3.1. Fundus Camera
7.3.2. Scanning Laser Ophthalmoscope
7.3.3. Wide Field Camera
8. Fluorescein Angiography Market, by Imaging Technology
8.1. Introduction
8.2. Analog
8.3. Digital
9. Fluorescein Angiography Market, by Procedure Type
9.1. Introduction
9.2. Diagnostic
9.3. Follow Up
9.4. Screening
10. Fluorescein Angiography Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Diagnostic Centers
10.4. Hospitals
10.5. Ophthalmology Clinics
11. Fluorescein Angiography Market, by Application
11.1. Introduction
11.2. Age Related Macular Degeneration
11.3. Diabetic Retinopathy
11.4. Retinal Vascular Occlusion
11.5. Uveitis
12. Fluorescein Angiography Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Fluorescein Angiography Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Fluorescein Angiography Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Canon Medical Systems Corporation
16.2. Carewell Instruments
16.3. CenterVue SpA
16.4. Chongqing Vision Star Optical Co Ltd
16.5. Costruzione Strumenti Oftalmici
16.6. Dajing Medical
16.7. Escalon Medical Corp
16.8. Forus Health Pvt Ltd
16.9. HAAG STREIT GROUP
16.10. Heidelberg Engineering GmbH
16.11. Icare Finland Oy
16.12. Konan Medical USA Inc
16.13. Kowa Company Ltd.
16.14. Medimaging Integrated Solution Inc
16.15. MGI Instruments
16.16. Naugra Medical
16.17. NIDEK Co. Ltd.
16.18. Optomed Oy
16.19. Optovue Incorporated
16.20. Perlong Medical Equipment Co Ltd
16.21. Phelcom Technologies
16.22. Rexxam Co Ltd
16.23. Suzhou Thriving Medical Equipment Corp
16.24. Tomey Corporation
16.25. Topcon Corporation
16.26. Ziemer Ophthalmic Systems AG
List of Figures
FIGURE 1. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DYE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DYE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DYE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SYRINGES & NEEDLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SYRINGES & NEEDLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SYRINGES & NEEDLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FUNDUS CAMERA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FUNDUS CAMERA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FUNDUS CAMERA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SCANNING LASER OPHTHALMOSCOPE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SCANNING LASER OPHTHALMOSCOPE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SCANNING LASER OPHTHALMOSCOPE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL WIDE FIELD CAMERA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL WIDE FIELD CAMERA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL WIDE FIELD CAMERA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ANALOG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANALOG MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ANALOG MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DIGITAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DIGITAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DIGITAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL FOLLOW UP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL FOLLOW UP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL FOLLOW UP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL AGE RELATED MACULAR DEGENERATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AGE RELATED MACULAR DEGENERATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AGE RELATED MACULAR DEGENERATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DIABETIC RETINOPATHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DIABETIC RETINOPATHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DIABETIC RETINOPATHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RETINAL VASCULAR OCCLUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL RETINAL VASCULAR OCCLUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL RETINAL VASCULAR OCCLUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL UVEITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL UVEITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL UVEITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 77. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 79. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 80. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 81. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 82. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 83. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 84. EUROPE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 103. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 104. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 105. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 106. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 107. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. AFRICA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 120. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 121. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 122. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 123. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 124. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. NATO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 128. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 129. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 130. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 131. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 132. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. G7 FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 136. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 137. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 138. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 140. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. BRICS FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 152. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 153. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 154. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 155. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 156. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. ASEAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 160. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 161. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 162. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 164. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. GCC FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 168. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 169. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 170. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 171. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 173. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. CHINA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 177. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 178. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 179. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 181. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 184. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 185. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 186. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 187. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 188. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 189. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. JAPAN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 192. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 193. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 194. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 195. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 197. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. INDIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 201. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 202. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 203. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 205. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. GERMANY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 217. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 218. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 219. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 220. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 221. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. AUSTRALIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 225. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 226. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 227. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 229. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. FRANCE FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 233. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 234. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 235. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 237. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. SOUTH KOREA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 241. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 242. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 243. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 244. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 245. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. ITALY FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 249. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 250. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 251. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 253. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. CANADA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 267. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 269. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 273. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 274. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 275. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 277. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. MEXICO FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 281. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 282. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 283. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY IMAGING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 284. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 285. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. SPAIN FLUORESCEIN ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 288. GLOBAL FLUORESCEIN ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Canon Medical Systems Corporation
  • Carewell Instruments
  • CenterVue SpA
  • Chongqing Vision Star Optical Co Ltd
  • Costruzione Strumenti Oftalmici
  • Dajing Medical
  • Escalon Medical Corp
  • Forus Health Pvt Ltd
  • HAAG STREIT GROUP
  • Heidelberg Engineering GmbH
  • Icare Finland Oy
  • Konan Medical USA Inc
  • Kowa Company Ltd.
  • Medimaging Integrated Solution Inc
  • MGI Instruments
  • Naugra Medical
  • NIDEK Co. Ltd.
  • Optomed Oy
  • Optovue Incorporated
  • Perlong Medical Equipment Co Ltd
  • Phelcom Technologies
  • Rexxam Co Ltd
  • Suzhou Thriving Medical Equipment Corp
  • Tomey Corporation
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.01 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.72 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Fluorescein Angiography - Global Strategic Business Report - Product Image

Fluorescein Angiography - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From
Fluorescein Angiography Market Outlook 2026-2034: Market Share, and Growth Analysis by Imaging Modality, Indication, End User, Dye Delivery Method - Product Image

Fluorescein Angiography Market Outlook 2026-2034: Market Share, and Growth Analysis by Imaging Modality, Indication, End User, Dye Delivery Method

  • Report
  • 160 Pages
  • Global
From
Cerebral Angiography Market - Global Forecast 2026-2032 - Product Image

Cerebral Angiography Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Angiography Equipment Market - Global Forecast 2026-2032 - Product Image

Angiography Equipment Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Coronary Angiography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Coronary Angiography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Fluorescein Angiography Market

Fluorescein angiography is a medical imaging technique utilized predominantly within the field of ophthalmology. The process involves injecting a fluorescent dye, typically fluorescein, into the bloodstream. As the dye circulates through the blood vessels of the retina and choroid—which are situated at the back of the eye—a specialized camera equipped with filters that let through only the specific wavelength of the fluorescing dye captures images. These photographs reveal the flow of blood through the retinal and choroidal vessels, allowing clinicians to diagnose conditions such as diabetic retinopathy, macular degeneration, and ocular vascular disorders. Fluorescein angiography is considered an essential part of radiographic imaging for ocular diagnoses, though it does fall into a niche category compared to more broadly used radiographic techniques such as X-ray, MRI, or CT scans. The output of this process is vital for treatment planning as it can detect abnormalities that may require interventions such as laser surgery or injections. Within the market, numerous companies specialize in manufacturing the fluorescein dye, as well as the angiography imaging equipment required for the procedure. Prominent players in this sector include Novartis AG (through its subsidiary Alcon), Carl Zeiss Meditec AG, Topcon Corporation, and Heidelberg Engineering GmbH. These companies provide a range of products from the fluorescein dye itself to advanced imaging systems, which contribute to the effective execution of fluorescein angiography. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.